Literature DB >> 20133649

Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.

Barbara Cellini1, Riccardo Montioli, Alessandro Paiardini, Antonio Lorenzetto, Fabio Maset, Tiziana Bellini, Elisa Oppici, Carla Borri Voltattorni.   

Abstract

G41 is an interfacial residue located within the alpha-helix 34-42 of alanine:glyoxylate aminotransferase (AGT). Its mutations on the major (AGT-Ma) or the minor (AGT-Mi) allele give rise to the variants G41R-Ma, G41R-Mi, and G41V-Ma causing hyperoxaluria type 1. Impairment of dimerization in these variants has been suggested to be responsible for immunoreactivity deficiency, intraperoxisomal aggregation, and sensitivity to proteasomal degradation. However, no experimental evidence supports this view. Here we report that G41 mutations, besides increasing the dimer-monomer equilibrium dissociation constant, affect the protein conformation and stability, and perturb its active site. As compared to AGT-Ma or AGT-Mi, G41 variants display different near-UV CD and intrinsic emission fluorescence spectra, larger exposure of hydrophobic surfaces, sensitivity to Met53-Tyr54 peptide bond cleavage by proteinase K, decreased thermostability, reduced coenzyme binding affinity, and catalytic efficiency. Additionally, unlike AGT-Ma and AGT-Mi, G41 variants under physiological conditions form insoluble inactive high-order aggregates (approximately 5,000 nm) through intermolecular electrostatic interactions. A comparative molecular dynamics study of the putative structures of AGT-Mi and G41R-Mi predicts that G41 --> R mutation causes a partial unwinding of the 34-42 alpha-helix and a displacement of the first 44 N-terminal residues including the active site loop 24-32. These simulations help us to envisage the possible structural basis of AGT dysfunction associated with G41 mutations. The detailed insight into how G41 mutations act on the structure-function of AGT may contribute to achieve the ultimate goal of correcting the effects of these mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133649      PMCID: PMC2840350          DOI: 10.1073/pnas.0908565107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Determining subunit dissociation constants in natural and recombinant proteins.

Authors:  L R Manning; A Dumoulin; W T Jenkins; R M Winslow; J M Manning
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules.

Authors:  J L Sussman; D Lin; J Jiang; N O Manning; J Prilusky; O Ritter; E E Abola
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-11-01

3.  Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.

Authors:  M B Coulter-Mackie; Q Lian
Journal:  Mol Genet Metab       Date:  2006-09-12       Impact factor: 4.797

Review 4.  Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.

Authors:  Christopher J Danpure
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

Review 5.  Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.

Authors:  Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2006-08-24

6.  Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.

Authors:  Marion B Coulter-Mackie; Qun Lian; Steve G Wong
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

7.  Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.

Authors:  P E Purdue; Y Takada; C J Danpure
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

8.  Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.

Authors:  C J Danpure; P E Purdue; P Fryer; S Griffiths; J Allsop; M J Lumb; K M Guttridge; P R Jennings; J I Scheinman; S M Mauer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.

Authors:  Barbara Cellini; Mariarita Bertoldi; Riccardo Montioli; Alessandro Paiardini; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

10.  Thermodynamic characterization of the osmolyte effect on protein stability and the effect of GdnHCl on the protein denatured state.

Authors:  Pannur Venkatesu; Ming-Jer Lee; Ho-Mu Lin
Journal:  J Phys Chem B       Date:  2007-06-29       Impact factor: 2.991

View more
  21 in total

1.  Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

Authors:  Katharina Hopp; Andrea G Cogal; Eric J Bergstralh; Barbara M Seide; Julie B Olson; Alicia M Meek; John C Lieske; Dawn S Milliner; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

2.  Phosphorylation in the catalytic cleft stabilizes and attracts domains of a phosphohexomutase.

Authors:  Jia Xu; Yingying Lee; Lesa J Beamer; Steven R Van Doren
Journal:  Biophys J       Date:  2015-01-20       Impact factor: 4.033

Review 3.  Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.

Authors:  Ania C Muntau; João Leandro; Michael Staudigl; Felix Mayer; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2014-04-01       Impact factor: 4.982

4.  Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.

Authors:  Sonia Fargue; John Knight; Ross P Holmes; Gill Rumsby; Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2016-02-06

5.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

6.  Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.

Authors:  Mirco Dindo; Elisa Oppici; Daniele Dell'Orco; Rosa Montone; Barbara Cellini
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

7.  Rapid profiling of disease alleles using a tunable reporter of protein misfolding.

Authors:  Adrianne M C Pittman; Melissa D Lage; Vladimir Poltoratsky; Justin D Vrana; Alessandro Paiardini; Alessandro Roncador; Barbara Cellini; Robert M Hughes; Chandra L Tucker
Journal:  Genetics       Date:  2012-08-24       Impact factor: 4.562

8.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

9.  Molecular requirements for peroxisomal targeting of alanine-glyoxylate aminotransferase as an essential determinant in primary hyperoxaluria type 1.

Authors:  Krisztián Fodor; Janina Wolf; Ralf Erdmann; Wolfgang Schliebs; Matthias Wilmanns
Journal:  PLoS Biol       Date:  2012-04-17       Impact factor: 8.029

10.  Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview.

Authors:  Barbara Cellini; Riccardo Montioli; Elisa Oppici; Carla Borri Voltattorni
Journal:  Open Biochem J       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.